Health GeneTech Corp.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
1. Gut Health and Colorectal Cancer Methylation Test
2. Congenital Risk and Trait Assessment
3. AccuGen® Health GeneTech Corp. Common Pathogenic Microorganism Detection
4. Gut Microbiota Test
5. Highly Customized Bioinformatics Analysis Services
6. Professional OEM Services: Illumina Microarrays, Illumina Sequencing, Nanopore Sequencing
2. Congenital Risk and Trait Assessment
3. AccuGen® Health GeneTech Corp. Common Pathogenic Microorganism Detection
4. Gut Microbiota Test
5. Highly Customized Bioinformatics Analysis Services
6. Professional OEM Services: Illumina Microarrays, Illumina Sequencing, Nanopore Sequencing
The content above was translated by Ai
Founded Year
2010
Unified Business No.
53260314
Status
Active
Number of Employees
0
Total Paid-in
Capital
100,000,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Health GeneTech Corp. is the most professional bioinformatics and gene technology company in Taiwan. Founded in 2010 by a group of faculty and students from the Institute of Bioinformatics and Systems Biology at National Chiao Tung University in Taiwan, along with industry professionals, the company takes bioinformatics analysis and biotechnology research and development as its core. It provides the best services for domestic and international gene technology products and researchers dedicated to genomic research, pioneering a new path for biotechnology research and development to jointly foster the well-being of human health. Combining gene technology laboratories and bioinformatics analysis, the company provides professional and reliable scientific research services and public health genetic testing through biochips, next-generation sequencing, and third-generation sequencing. Furthermore, leveraging its leading bioinformatics analysis capabilities, it focuses on the development of reagents and reporting systems, expanding into the global market with a focus on testing products.
The content above was translated by Ai
